Skip to main content
S 892 115th Congress Senate Crime and Law Enforcement Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Health personnel Licensing and registrations Prescription drugs

Opioid Addiction Prevention Act of 2017

Introduced: April 7, 2017 Introduced by: Gillibrand, Kirsten E. Democratic · New York See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 7, 2017
Read twice and referred to the Committee on the Judiciary.
Apr 7, 2017
Introduced in Senate
 Plain-English summary Congressional Research Service

Opioid Addiction Prevention Act of 2017

This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.

An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.

What's happening now April 7, 2017

Read twice and referred to the Committee on the Judiciary.

 Committees of jurisdiction 1